England's Chief Medical Officer, Prof Sir Chris Whitty, has stated that relying on weight-loss drugs to tackle obesity would be a societal and medical failure.
Sir Chris, speaking at the Medical Journalists' Association annual lecture, emphasized that while drugs like Wegovy and Mounjaro are "transformational" for those who need them, they should only be used by a "very small minority".
The UK has seen a significant rise in obesity levels, with around two thirds of adults being overweight or obese, whereas France has maintained relatively stable obesity levels over the past three decades.
Obesity Concerns
Sir Chris expressed concern about obesity due to the increased risk of cancers, heart disease, type 2 diabetes, and infections associated with larger waistlines.
Weight-loss drugs, which mimic hormones produced by the body to suppress appetite, are offered by the NHS through specialist weight management services, but there is also a large private market for these medicines.
Usage of Weight-Loss Drugs
An estimated 1.6 million people in the UK have tried weight-loss drugs in the past year, according to reports.
Sir Chris warned that if a high proportion of the population ended up on these drugs, it would be a "societal failure", and instead, the UK should focus on learning from countries like France, which have been successful in promoting healthy eating habits.
Public Health Approach
Sir Chris emphasized the need for a public health approach, rather than relying solely on drugs, and criticized the aggressive marketing of junk food to children, which contributes to obesity.
He suggested that reducing the amount of fat and sugar in diets does not mean eating unpleasant food, citing France as an example of a country that has managed to promote healthy and tasty food.
